We are live on ! Find out more
ZEPP

Zepp Health

18 hedge funds and large institutions have $8.78M invested in Zepp Health in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.05% more ownership

Funds ownership: 1.64%1.68% (+0.05%)

22% less funds holding

Funds holding: 2318 (-5)

29% less capital invested

Capital invested by funds: $12.4M → $8.78M (-$3.63M)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
18
Holders Change
-5
Holders Change %
-21.74%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
5
Closed
6
Calls
$24K
Puts
Net Calls
+$24K
Net Calls Change
+$20K

ZEPP Hedge Fund Activity: Q1 2024 in Review

18 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zepp Health (ZEPP) for Q1 2024, worth a combined $8.78M — down 29% from $12.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ZEPP and 1 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $49.8K. The largest seller was Citadel Advisors, exiting entirely with an estimated $93.8K sold.

  • 18 institutional investors held Zepp Health (ZEPP) as of Q1 2024, down from 23 in Q4 2023.
  • Funds reported $8.78M of Zepp Health stock for Q1 2024, down 29% quarter-over-quarter.
  • 1 fund opened new Zepp Health positions in Q1 2024 and 6 closed out, a net change of -5 holders.
  • The largest Zepp Health buyer in Q1 2024 was Morgan Stanley, an estimated $49.8K added.
  • The largest Zepp Health seller in Q1 2024 was Citadel Advisors, an estimated $93.8K sold.

Based on aggregated 13F filings for Q1 2024.